Specimen findings and survival after preoperative 252Cf neutron brachytherapy for Stage II cervical carcinoma

Yosh Maruyama, Elvis Donaldson, John R. van Nagell, Justine Yoneda, Holly H. Gallion, D. Powell, Richard J. Kryscio

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Twenty-seven patients with operable Stage II cervical cancer with a mean diameter tumor of 8.0 cm were studied in a feasibility study using preoperative 252Cf implants plus whole-pelvis radiation to 45 Gy followed by extrafascial total abdominal hysterectomy and bilateral salpingo-oophorectomy 4 to 6 weeks later. Hysterectomy specimens were studied by a set protocol. With the protocol used, 13 27 (51%) specimens and abdominal stagings were negative for residual tumor. The survival rate for the patients with negative findings was 93% at 5 years. In 14 27 (49%) patients the specimens were positive for residual tumor. In contrast, the 5-year survival rate for this group was 46% (P < 0.001). In these patients several interrelated factors were determined to be of importance, i.e., (1) tumor size>8 cm in maximum diameter, (2) positive or negative residual tumor status, and (3) total dose of radiation given. Survival was lower for larger tumors and specimens were more likely to show residual tumor. A lower treatment dose led to more positive specimens, as well as to poorer survival. While the patients with Stage II disease fared very well when negative specimens were found, further prospective studies of the appropriate treatment for those with positive tumor specimens are needed.

Original languageEnglish (US)
Pages (from-to)252-259
Number of pages8
JournalGynecologic oncology
Volume43
Issue number3
DOIs
StatePublished - Dec 1991

Fingerprint

Dive into the research topics of 'Specimen findings and survival after preoperative <sup>252</sup>Cf neutron brachytherapy for Stage II cervical carcinoma'. Together they form a unique fingerprint.

Cite this